Department of Microbial Natural Products (MINS), Helmholtz Institute for Pharmaceutical Research Saarland (HIPS)-Helmholtz Centre for Infection Research (HZI), Campus E8 1, 66123 Saarbrücken, Germany.
German Center for Infection Research (DZIF), Partner site Hannover-Braunschweig, Inhoffenstr. 7, 38124 Braunschweig, Germany.
Mar Drugs. 2018 Sep 5;16(9):314. doi: 10.3390/md16090314.
Prior to 2005, the vast majority of characterized myxobacteria were obtained from terrestrial habitats. Since then, several species of halotolerant and even obligate marine myxobacteria have been described. Chemical analyses of extracts from these organisms have confirmed their ability to produce secondary metabolites with unique chemical scaffolds. Indeed, new genera of marine-derived myxobacteria, particularly , have been shown to produce novel chemical scaffolds that differ from those observed in soil myxobacteria. Further studies have shown that marine sponges and terrestrial myxobacteria are capable of producing similar or even identical secondary metabolites, suggesting that myxobacterial symbionts may have been the true producers. Recent in silico analysis of the genome sequences available from six marine myxobacteria disclosed a remarkably versatile biosynthetic potential. With access to ever-advancing tools for small molecule and genetic evaluation, these studies suggest a bright future for expeditions into this yet untapped resource for secondary metabolites.
在 2005 年之前,绝大多数已被描述的粘细菌都来自陆地生境。此后,描述了几种耐盐甚至专性海洋粘细菌。从这些生物体中提取的化学分析证实了它们产生具有独特化学结构的次生代谢物的能力。事实上,海洋来源的粘细菌的新属,特别是,已被证明能产生与土壤粘细菌观察到的不同的新型化学结构。进一步的研究表明,海洋海绵和陆地粘细菌能够产生相似甚至相同的次生代谢物,这表明粘细菌共生体可能是真正的生产者。最近对来自六种海洋粘细菌的基因组序列的计算机分析揭示了一种非常多样的生物合成潜力。随着对小分子和遗传评估的不断发展的工具的使用,这些研究为进入这个尚未开发的次生代谢物资源的探索带来了光明的前景。